1. Home
  2. COMP vs ALKS Comparison

COMP vs ALKS Comparison

Compare COMP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COMP
  • ALKS
  • Stock Information
  • Founded
  • COMP 2012
  • ALKS 1987
  • Country
  • COMP United States
  • ALKS Ireland
  • Employees
  • COMP N/A
  • ALKS N/A
  • Industry
  • COMP EDP Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • COMP Technology
  • ALKS Health Care
  • Exchange
  • COMP Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • COMP 4.9B
  • ALKS 4.9B
  • IPO Year
  • COMP 2021
  • ALKS 1991
  • Fundamental
  • Price
  • COMP $9.46
  • ALKS $27.87
  • Analyst Decision
  • COMP Buy
  • ALKS Strong Buy
  • Analyst Count
  • COMP 8
  • ALKS 14
  • Target Price
  • COMP $9.75
  • ALKS $41.29
  • AVG Volume (30 Days)
  • COMP 7.2M
  • ALKS 1.9M
  • Earning Date
  • COMP 10-29-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • COMP N/A
  • ALKS N/A
  • EPS Growth
  • COMP N/A
  • ALKS 21.99
  • EPS
  • COMP N/A
  • ALKS 2.08
  • Revenue
  • COMP $6,290,200,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • COMP $24.34
  • ALKS N/A
  • Revenue Next Year
  • COMP $12.93
  • ALKS $1.66
  • P/E Ratio
  • COMP N/A
  • ALKS $13.19
  • Revenue Growth
  • COMP 21.23
  • ALKS N/A
  • 52 Week Low
  • COMP $5.10
  • ALKS $25.17
  • 52 Week High
  • COMP $10.25
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • COMP 61.66
  • ALKS 48.33
  • Support Level
  • COMP $9.15
  • ALKS $26.40
  • Resistance Level
  • COMP $9.60
  • ALKS $28.65
  • Average True Range (ATR)
  • COMP 0.36
  • ALKS 1.13
  • MACD
  • COMP -0.06
  • ALKS -0.20
  • Stochastic Oscillator
  • COMP 59.84
  • ALKS 41.41

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: